PAPER Abbasi J
SEARCH RESULTS
3963 RESULTS
PAPER Yeh TC, Tzeng NS, Li JC, Huang YC, Hsieh HT, Chu CS, Liang CS
Mortality Risk of Atypical Antipsychotics for Behavioral and Psychological Symptoms of Dementia: A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis of Randomized Controlled Trials.
J Clin Psychopharmacol. 2019 Sep/Oct;39(5):472-478. PubMed: 31433335PAPER Wade AT, Elias MF, Murphy KJ
Adherence to a Mediterranean diet is associated with cognitive function in an older non-Mediterranean sample: findings from the Maine-Syracuse Longitudinal Study.
Nutr Neurosci. 2019 Aug 21;:1-12. PubMed: 31432770PAPER Trist BG, Hare DJ, Double KL
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.
Aging Cell. 2019 Dec;18(6):e13031. Epub 2019 Aug 20 PubMed: 31432604PAPER Yang W, Xie J, Qiang Q, Li L, Lin X, Ren Y, Ren W, Liu Q, Zhou G, Wei W, Saiyin H, Ma L
Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease.
Neurosci Bull. 2019 Dec;35(6):1024-1034. Epub 2019 Aug 20 PubMed: 31432317Proteomics Uncovers Potential Markers, Subtypes of Alzheimer’s
CONFERENCE COVERAGE 2019-08-22 Conference Coverage In the last three decades, scientists have made strides in using biomarkers to diagnose Alzheimer’s disease and track its progression. Along with cerebrospinal fluid Aβ, tau, and phospho-tau, a handful of new markers, such as neurofila
Synaptic Proteins in CSF: New Markers of Cognitive Decline?
CONFERENCE COVERAGE 2019-08-22 Conference Coverage Plasma tests for Aβ and phospho-tau may have stolen the show at this year’s Alzheimer’s Association International Conference, held July 14-18 in Los Angeles, but proteomic and synaptic markers were not that far behind. A neural pentrax
PSEN1 N39Y
MUTATIONS PSEN1 73637532 GRCh37/hg19 A T Exon 4 Point, Missense Coding Unknown. Multiple in silico algorithms yielded conflicting results. Unknown N39Y Alzheimer's Disease: Not ClassifiedAlzheimer's Disease This mutation was identified in a genetic screen
Frank Happ
Marc Vandermeeren
F. Annie Evangaline Fernands
ResearchCOIMBATORE, India
PAPER Lara Ordónez AJ, Fernández B, Fdez E, Romo-Lozano M, Madero-Pérez J, Lobbestael E, Baekelandt V, Aiastui A, López de Munaín A, Melrose HL, Civiero L, Hilfiker S
RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase-mediated centrosomal cohesion and ciliogenesis deficits.
Hum Mol Genet. 2019 Nov 1;28(21):3552-3568. PubMed: 31428781PAPER Lindestam Arlehamn CS, Garretti F, Sulzer D, Sette A
Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.
Curr Opin Immunol. 2019 Aug;59:115-120. Epub 2019 Aug 17 PubMed: 31430650PAPER Pang SY, Ho PW, Liu HF, Leung CT, Li L, Chang EE, Ramsden DB, Ho SL
The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease.
Transl Neurodegener. 2019;8:23. Epub 2019 Aug 16 PubMed: 31428316PAPER Araki K, Yagi N, Aoyama K, Choong CJ, Hayakawa H, Fujimura H, Nagai Y, Goto Y, Mochizuki H
Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein.
Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):17963-17969. Epub 2019 Aug 19 PubMed: 31427526Current Filters
- Date Range : Aug 2019 to Nov 2019 x